Many tumor cells, including lung cancer, prostate cancer, breast cancer, and melanoma, can release PD-L1-expressing exosomes, which prevent the activation of effector T cells by binding to PD-1 and promote the formation of a suppressive tumor immune microenvironment (58). This evidence concerns the gene PDCD1 and melanoma.